You are viewing an incomplete version of our website. Please click to reload the website as full version.

OLIG2 antibody (Oligodendrocyte Lineage Transcription Factor 2) (AA 80-130)

Details for Product anti-OLIG2 Antibody No. ABIN350657, Supplier: Log in to see
Antigen
  • olig3.2
  • MGC89336
  • OLIG2
  • BHLHB1
  • OLIGO2
  • PRKCBP2
  • RACK17
  • bHLHe19
  • wu:fc64g09
  • AI604895
  • Bhlhb1
  • Olg-2
  • Oligo2
  • RK17
Epitope
AA 80-130
15
14
13
11
9
8
5
4
3
3
2
2
2
1
1
1
1
1
1
Reactivity
Human, Rat (Rattus), Mouse (Murine)
79
48
28
3
2
1
1
Host
Rabbit
82
20
3
1
Clonality
Polyclonal
Conjugate
This OLIG2 antibody is un-conjugated
4
2
2
2
2
2
1
Application
Immunohistochemistry (IHC), Western Blotting (WB)
98
53
35
19
12
12
10
4
4
1
1
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Available images

Immunogen A synthetic peptide from aa region 80-130 of human OLIG2 conjugated to blue carrier protein was used as the antigen. The peptide is homologous in rat and mouse.
Isotype IgG
Specificity Specific for OLIG2.
Alternative Name OLIG2 (OLIG2 Antibody Abstract)
Background Function: Required for oligodendrocyte and motor neuron specification in the spinal cord, as well as for the development of somatic motor neurons in the hindbrain. Cooperates with OLIG1 to establish the pMN domain of the embryonic neural tube. Antagonist of V2 interneuron and of NKX2-2-induced V3 interneuron development.
Subcellular location: Nucleus. Cytoplasm
Tissue specificity: Expressed in the brain, in oligodendrocytes. Strongly expressed in oligodendrogliomas, while expression is weak to moderate in astrocytomas. Expression in glioblastomas highly variable. Involvement in disease: A chromosomal aberration involving OLIG2 may be a cause of a form of T-cell acute lymphoblastic leukemia (T-ALL). Translocation t(14,21)(q11.2,q22) with TCRA. Also known as: Basic helix loop helix protein class B 1, BHLHB1, olig2, OLIGO2, Oligodendrocyte specific bHLH transcription factor 2, Oligodendrocyte transcription factor 2, PRKCBP2, Protein kinase C binding protein 2, Protein kinase C binding protein RACK17, RACK17.
Application Notes A concentration of 10-50 µg/ml is recommended.
The optimal concentration should be determined by the end user.
Not yet tested in other applications.
Restrictions For Research Use only
Format Lyophilized
Reconstitution Reconstitute in 100 µL of sterile water. Centrifuge to remove any insoluble material.
Handling Advice Avoid freeze and thaw cycles.
Storage 4 °C/-20 °C
Storage Comment Maintain the lyophilised/reconstituted antibodies frozen at -20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles.
Expiry Date 12 months
Supplier Images
Western Blotting (WB) image for anti-OLIG2 antibody (Oligodendrocyte Lineage Transcription Factor 2) (AA 80-130) (ABIN350657) WB on mouse brain lysate (denatured, reduced) using Rabbit antibody to n-terminal reg...
Background publications Ota, Suzuki, Nishikawa et al.: "Complete sequencing and characterization of 21,243 full-length human cDNAs. ..." in: Nature genetics, Vol. 36, Issue 1, pp. 40-5, 2003 (PubMed).

Lu, Park, Noll et al.: "Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, Issue 19, pp. 10851-6, 2001 (PubMed).

Marie, Sanson, Mokhtari et al.: "OLIG2 as a specific marker of oligodendroglial tumour cells." in: Lancet, Vol. 358, Issue 9278, pp. 298-300, 2001 (PubMed).

Wang, Jani-Sait, Escalon et al.: "The t(14,21)(q11.2,q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 97, Issue 7, pp. 3497-502, 2000 (PubMed).